BioMedNewsBreaks — Safety Shot (NASDAQ: SHOT) Launches New Four-Ounce Bottles for Flagship Product

Safety Shot (NASDAQ: SHOT), a wellness and dietary supplement company, has unveiled new bottling for its revolutionary new formula. A first-of-its-kind functional beverage, Safety Shot contains essential B vitamins, antioxidants, electrolytes and nootropics designed to boost mental clarity, energy and overall mood. The product is now available in convenient, on-the-go four-ounce bottles, making it more portable for enhanced accessibility and convenience. Safety Shot is the world’s first beverage to reduce blood alcohol content in as little as 30 minutes by supporting its metabolism. According to the announcement, the new smaller bottles will be available in Q3 in convenience stores and liquor stores across the United States during Q3 2023. “We are excited to offer our customers more convenient options to enjoy the benefits of Safety Shot,” said Safety Shot chief revenue officer Josh Wagner in the press release. “Our new four-ounce bottles are designed to fit seamlessly into any routine, ensuring that our customers can carry our revolutionary formula at ease, no matter where they are.”

To view the full press release, visit https://ibn.fm/pzP2U

About Safety Shot Inc.

Safety Shot, a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while also boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars throughout 2024. For more information about the company, visit www.SafetyShotHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.